Prescription drug · NDA
Crinone (Progesterone) NDC 0023-6151
Progesterone 90 mg/1.125g · Gel · Vaginal · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0023-6151-08 | 0002361510800023615108 | 15 APPLICATOR in 1 CARTON (0023-6151-08) / 1.125 g in 1 APPLICATORMarketed from May 13, 1997 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Crinone
- Generic name (nonproprietary)
- progesterone
- Active ingredients
- Progesterone — 90 mg/1.125g
- Dosage form
- Gel
- Route
- Vaginal
- Labeler
- Allergan, Inc.NDC labeler code 0023
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020701
- Marketing start
- Listing expires
- Other FDA classes
- Progesterone (Chemical structure)
- Identifiers
- Product ID 0023-6151_ab1523af-0bbb-4231-a12c-ac52e3ec91cdSPL ID ab1523af-0bbb-4231-a12c-ac52e3ec91cdSPL set ID 75e97aa1-daa4-45f9-b2e2-1a371302914eRxCUI 153579, 153580, 312643, 312645UNII 4G7DS2Q64Y
- Pharmacologic class
- Progesterone
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N400023615108followed by a unit qualifier and the quantityPackage 00023-6151-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Assisted Reproductive Technology Crinone 8% is indicated for progesterone supplementation or replacement as part of an Assisted Reproductive Technology ("ART") treatment for infertile women with progesterone deficiency. Secondary Amenorrhea Crinone 4% is indicated for the treatment of secondary amenorrhea. Crinone 8% is indicated for use in women who have failed to respond to treatment with Crinone 4%.
Excerpt only. Read the full label for complete information.
About NDC 0023-6151
- What is NDC 0023-6151?
- 0023-6151 is the product NDC for Crinone (progesterone), Progesterone 90 mg/1.125g gel, listed with the FDA by Allergan, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Crinone (Progesterone).
- What is the active ingredient?
- Progesterone.
- Who is the labeler?
- Allergan, Inc., NDC labeler code 0023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Crinone?
- 1 other product NDC are listed under this name. See all Crinone NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Crinone products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Crinoneprogesterone | Progesterone 45 mg/1.125g | GelVaginal | Allergan, Inc. | 0023-6150 | 00023-6150-04 |
Other NDCs under NDA 020701
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Crinoneprogesterone | Progesterone 45 mg/1.125g | GelVaginal | Allergan, Inc. | 0023-6150 |